#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant fibrous histiocytoma Amyotrophic lateral sclerosis Congenital pseudarthrosis Ocular myasthenia Pseudomyxoma peritonei Arginase deficiency Autoimmune myositis Vulval cancer Ichthyosis Biliary cancer metastatic Mantle cell lymphoma stage III Paraganglion neoplasm Small intestine neuroendocrine tumour Microscopic polyangiitis Marginal zone lymphoma refractory More trials…

    Learn about Rare Diseases

    Myxofibrosarcoma – Basic Information Von Willebrand’s disease – Trials in Disease Paroxysmal nocturnal haemoglobinuria – Basic Information Cystic fibrosis Nephroblastoma MELAS syndrome – Life with Disease Hereditary ataxia – Trials in Disease Marginal zone lymphoma refractory – Diagnostics Basal cell naevus syndrome – Life with Disease Glomerulonephritis rapidly progressive – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ixazomib Calcium Oxybate Rusfertide TEV-53408 Florbetaben (18F) Diclofenac Epolamine XELAFASLATIDE Efgartigimod Alfa Empasiprubart Anv600 Cilgavimab Topiramate Raludotatug Deruxtecan FG001 Riociguat Arsenic Trioxide Triamcinolone Teclistamab [18F]Mc225 Fentanyl Citrate More therapies…

    Learn about Your Condition

    Uterine leiomyosarcoma Immunosuppression Constipation Habitual abortion Sarcoma Drug use disorder Dyspepsia Influenza Prodromal Alzheimer's disease Pituitary tumour benign Pulmonary fibrosis Craniotomy Rectal adenocarcinoma Cholecystitis acute Skin disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Neuropsychiatrie s.r.o.

Neuropsychiatrie s.r.o.

Terronska 580/19, Bubenec, Prague, 160 00, Czechia

Want to learn more about this study or check if you can participate? Contact us.

  • A Study of ACP-204 Tartrate for Adults With Lewy Body Dementia Psychosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dementia with Lewy bodies
    Investigated Drugs:
    • Acp-204 Tartrate
    Bulgaria Czechia France Italy

  • A Study Testing ACP-204 Tartrate Compared to Placebo for Adults with Lewy Body Dementia Psychosis

    Recruiting

    2 1
    Investigated Diseases:
    • Dementia with Lewy bodies
    Investigated Drugs:
    • Acp-204 Tartrate
    Bulgaria Czechia France Italy

  • A study testing xanomeline tartrate and trospium chloride for treating agitation in patients with Alzheimer’s disease

    Recruiting

    3 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Czechia France Hungary Italy Poland

  • Study of xanomeline tartrate and trospium chloride combination for cognitive impairment in people with mild to moderate Alzheimer’s disease

    Recruiting

    3 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Croatia Czechia Germany Greece Italy The Netherlands +3

  • Study of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer’s disease patients: Long-term safety evaluation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Bulgaria Croatia Czechia France Greece Hungary +5

  • Study of incobotulinumtoxinA injections for prevention of chronic migraine in adult patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    Austria Czechia Denmark France Germany Italy +3

  • Study on ITI-1284 for Treating Agitation in Alzheimer’s Patients

    Recruiting

    2 1
    Investigated Drugs:
    • Iti-1284
    Bulgaria Croatia Czechia Romania Slovakia Spain

  • Study on the Safety and Effects of NTRX-07 for Patients with Mild Cognitive Impairment or Mild to Moderate Alzheimer’s Disease

    Recruiting

    2 1
    Investigated Diseases:
    • Cognitive disorder
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • (3-BENZYL-3-METHYL-2,3-DIHYDROBENZOFURAN-6- YL)(PIPERIDIN-1-YL)METHANONE
    Czechia Hungary Poland

  • Study of IncobotulinumtoxinA injections compared to placebo for prevention of episodic migraine attacks

    Recruiting

    3 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    Austria Czechia Denmark France Germany Italy +3

  • Study on the Safety and Effectiveness of PRI-002 for Patients with Mild Cognitive Impairment or Mild Dementia Due to Alzheimer’s Disease

    Not yet recruiting

    2 1
    Investigated Drugs:
    • D-Prolyl-D-Threonyl-D-Leucyl-D-Histidyl-D-Threonyl-D-Histidyl-D-Asparaginyl-D-Arginyl-D-Arginyl-D-Arginyl-D-Arginyl-D-Arginine Amide Acetate
    Czechia France Germany Italy The Netherlands Poland +1
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!